Bahl & Gaynor’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-52,048
Closed -$1.93M – 365
2018
Q2
$1.93M Buy
52,048
+916
+2% +$35K 0.02% 218
2018
Q1
$1.93M Buy
51,132
+1,812
+4% +$64K 0.02% 216
2017
Q4
$1.6M Buy
49,320
+2,720
+6% +$86.4K 0.02% 237
2017
Q3
$1.41M Sell
46,600
-1,840
-4% -$54.6K 0.02% 232
2017
Q2
$1.42M Buy
48,440
+16,280
+51% +$445K 0.02% 227
2017
Q1
$817K Buy
32,160
+3,600
+13% +$92.9K 0.01% 272
2016
Q4
$735K Buy
28,560
+4,360
+18% +$115K 0.01% 278
2016
Q3
$663K Buy
24,200
+2,240
+10% +$61.5K 0.01% 290
2016
Q2
$619K Buy
21,960
+1,540
+8% +$39.6K 0.01% 291
2016
Q1
$482K Buy
20,420
+200
+1% +$4.41K 0.01% 314
2015
Q4
$455K Buy
20,220
+1,860
+10% +$42.4K 0.01% 323
2015
Q3
$424K Buy
18,360
+2,800
+18% +$70.2K 0.01% 332
2015
Q2
$383K Buy
+15,560
New +$389K 0.01% 356

Other funds holding TECH

Bahl & Gaynor's TECH Position: Q3 2018 in Review

Bahl & Gaynor sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 52,048 shares — an estimated $1.93M sold.

Bahl & Gaynor first reported a position in TECH in Q2 2015 and held it in 13 quarters. The position peaked at $1.93M in Q1 2018. 344 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

  • Bahl & Gaynor reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
  • Bahl & Gaynor sold 52,048 Bio-Techne shares in Q3 2018, an estimated $1.93M.
  • Bahl & Gaynor first reported a position in Bio-Techne in Q2 2015 and held it in 13 quarters.
  • Bahl & Gaynor's Bio-Techne position peaked at $1.93M in Q1 2018.
  • 344 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on Bahl & Gaynor's 13F filing for Q3 2018, filed 9 Nov 2018.